Experimental Electronic Comb in China: In Mice Tests, Hair Regrowth Beat Minoxidil
Scientists at China's Beihang University have created an experimental electronic comb called 'Detangle' to help prevent hair loss and promote new hair growth.
It was developed mainly to address male hair thinning, known as androgenetic alopecia.
According to a South China Morning Post report, the device combines the mechanical method of combing hair with electrical stimulation and technology that delivers medicine to a specific site, stimulating the hair follicles or roots.
The report said about 80 percent of men experience this kind of hair loss during their lifetime, which negatively affects their mental state and normal life.
Details of the new invention were presented in a study titled 'Combing-Triggered Electrostimulation Synchronizing Deep Delivery for Rapid Hair Regrowth in Androgenetic Alopecia', published in the journal Nature Communications.
The comb's features include electronic teeth fitted with electrodes of different heights and drug-holding particles. These create an effective electric field around the area of the hair roots and help hair grow quickly.
In experimental application on mice, the method was found to be much more effective than minoxidil, the main ingredient of 'Rogaine', widely used to treat hair loss. The researchers said that while the usual drug produced a hair regrowth rate of about 70 percent, the new method reached about 100 percent in just one month.
Current treatments for male baldness have several limitations. 'Minoxidil' lotion applied to the head can take up to a year to show effectiveness and must be used regularly. Its side effects can include headaches and scalp discomfort or itching.
By contrast, 'finasteride', known as 'Propecia', is quite effective in the early stages of hair loss, but its side effects can include depression and sexual problems. Hair transplant is effective, but it is quite expensive, painful and surgery-dependent.
However, the 'Detangle' comb has so far been tested only on mice. There is still no confirmed proof that the same good results will be obtained in the human body. The study noted that many more tests are therefore needed to verify the device's effectiveness and safety in humans.




